Insider · CIK 0001741283
Robert Ang
ceopresidentofficerdirector
Files at VOR (Vor Biopharma Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2025 | VOR Vor Biopharma Inc. | FTax withholding Common Stock | -2,361 | $0.56 | $1,322 | 911,318 | May 7, 2025 |
| May 1, 2025 | VOR Vor Biopharma Inc. | FTax withholding Common Stock | -2,751 | $0.66 | $1,816 | 916,201 | May 2, 2025 |
| May 1, 2025 | VOR Vor Biopharma Inc. | FTax withholding Common Stock | -2,522 | $0.66 | $1,665 | 913,679 | May 2, 2025 |
| Feb 6, 2025 | VOR Vor Biopharma Inc. | FTax withholding Common Stock | -2,787 | $1.50 | $4,181 | 918,952 | Feb 7, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | FTax withholding Common Stock | -3,248 | $1.34 | $4,352 | 784,239 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Common Stock | +137,500 | $0.00 | $0 | 921,739 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -147,294 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +147,294 | $0.00 | $0 | 147,294 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -652,086 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +652,086 | $0.00 | $0 | 652,086 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -51,060 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +51,060 | $0.00 | $0 | 51,060 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -376,000 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +376,000 | $0.00 | $0 | 376,000 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -172,500 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +172,500 | $0.00 | $0 | 172,500 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -257,500 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +257,500 | $0.00 | $0 | 257,500 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -470,000 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +470,000 | $0.00 | $0 | 470,000 | Feb 5, 2025 |
| Feb 3, 2025 | VOR Vor Biopharma Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +825,000 | $0.00 | $0 | 825,000 | Feb 5, 2025 |
| Nov 6, 2024 | VOR Vor Biopharma Inc. | FTax withholding Common Stock | -2,361 | $0.86 | $2,030 | 787,487 | Nov 8, 2024 |
| Nov 1, 2024 | VOR Vor Biopharma Inc. | FTax withholding Common Stock | -2,751 | $0.80 | $2,201 | 789,848 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.